Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.
暂无分享，去创建一个
Edward S. Kim | S. Lippman | I. Wistuba | J. Lee | D. Shin | A. Gillenwater | L. Mao | Ximing Tang | V. Papadimitrakopoulou | Jack W. Martin | J. Myers | P. Saintigny | M. Lingen | J. S. Gutkind | W. William | E. Blair | E. Cohen | N. Vigneswaran | Heather Y. Lin | J. Boyle | T. Meiller | Nancy Shinn | A. El-Naggar | J. Heymach | J. Gutkind | J. Lee